Escondido, CA, United States of America

Roumen A Bogoev

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Novex. Active years: 2000.

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roumen A Bogoev: Innovator in Gel Electrophoresis Technology

Introduction

Roumen A Bogoev is a notable inventor based in Escondido, California. He has made significant contributions to the field of gel electrophoresis, particularly in the preparation of denatured nucleic acids. His innovative work has implications for various applications in molecular biology and biochemistry.

Latest Patents

Roumen A Bogoev holds a patent for a sample buffer and methods for high-resolution gel electrophoresis. This patent enhances the preparation of denatured nucleic acids and improves the application of these samples in gel electrophoresis systems. The method he developed results in enhanced band flatness and sharpness, leading to higher resolution and throughput in electrophoresis.

Career Highlights

Roumen A Bogoev is currently associated with Novex, a company known for its advancements in laboratory technologies. His work at Novex has allowed him to focus on developing innovative solutions that address challenges in the field of electrophoresis.

Collaborations

Throughout his career, Roumen has collaborated with esteemed colleagues, including Timothy V Updyke and Song-Hua Ke. These collaborations have contributed to the advancement of technologies in their respective fields.

Conclusion

Roumen A Bogoev's contributions to gel electrophoresis technology exemplify the impact of innovation in scientific research. His patent and work at Novex highlight the importance of developing efficient methods for molecular analysis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…